GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

10405	Companies
217550	Keywords
147128	Articles
115133	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 02/10/2025 at 07:30, 1 year 3 months ago

GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders
GENFIT announces final terms for dual proposal to the 2025 OCEANEs holders, offering to repurchase bonds at EUR 32.00 or pay a consent fee of EUR 0.60 per bond. Proposals subject to bondholders' approval and closing of royalty financing

Repurchase Royalty Financing GENFIT Consent Fee 2025 OCEANEs
PRESS RELEASE

published on 02/10/2025 at 07:30, 1 year 3 months ago

GENFIT annonce les termes définitifs de sa double proposition aux porteurs d’OCEANEs 2025
GENFIT annonce les termes de sa double proposition aux porteurs d'OCEANEs 2025, incluant le rachat des obligations ou un paiement financier, liés au royalty financing avec HCRx. Modalités d'approbation et mise en œuvre

Rachat Royalty Financing GENFIT OCEANEs 2025 Contrepartie Financière
BRIEF

published on 02/06/2025 at 22:15, 1 year 3 months ago

GENFIT dévoile ses futurs essais cliniques et attentes pour 2025

Biopharmaceutique Essais Cliniques 2025 GENFIT ACLF
BRIEF

published on 02/06/2025 at 22:15, 1 year 3 months ago

GENFIT unveils its future clinical trials and expectations for 2025

Clinical Trials Biopharmaceutical 2025 GENFIT ACLF
PRESS RELEASE

published on 02/06/2025 at 22:10, 1 year 3 months ago

GENFIT présente le design de ses prochains essais cliniques et rappelle les grandes étapes de développement et données cliniques attendues en 2025
GENFIT présente le design de ses prochains essais cliniques pour son portefeuille ACLF et rappelle les données cliniques attendues en 2025. Le Directeur Général annonce quatre séries de données cliniques attendues d'ici fin 2025

Développement Essais Cliniques GENFIT ACLF Données Cliniques
PRESS RELEASE

published on 02/06/2025 at 22:10, 1 year 3 months ago

GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025
GENFIT outlines anticipated new clinical trial initiations, development milestones, and data readouts in 2025, focusing on Acute on-Chronic Liver Failure (ACLF) pipeline

Clinical Trials Biopharmaceutical 2025 GENFIT ACLF Pipeline
BRIEF

published on 01/30/2025 at 08:45, 1 year 3 months ago

GENFIT Announces €185 Million Royalty Financing Agreement

Biopharmaceutical Royalty Financing GENFIT Debt Resolution ACLF Development
BRIEF

published on 01/30/2025 at 08:45, 1 year 3 months ago

GENFIT annonce un accord de financement de 185 millions d'euros sous forme de redevances

Biopharmaceutique GENFIT Résolution De La Dette Financement Par Redevances Développement De L'ACLF
PRESS RELEASE

published on 01/30/2025 at 08:40, 1 year 3 months ago

GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan
GENFIT announces non-dilutive royalty financing agreement with HealthCare Royalty, resolving debt overhang. Transaction to strengthen ACLF pipeline and extend cash runway into 2027

HealthCare Royalty Royalty Financing GENFIT Debt Overhang ACLF Pipeline
BRIEF

published on 01/13/2025 at 22:15, 1 year 4 months ago

Bilan semestriel du contrat de liquidité de GENFIT avec le CIC

Bilan Semestriel Liquidité Crédit Industriel Et Commercial Titres GENFIT

Accesswire

Published on 05/14/2026 at 15:00, 14 minutes ago

Karbon-X Explores Clean Cooking and Fish Smoking Climate Initiative Concept in Senegal
Published on 05/14/2026 at 15:00, 14 minutes ago

ACCESS Newswire Celebrates PRSSA Bateman Competition Success and the Next Generation of Communications Leaders
Published on 05/14/2026 at 14:50, 24 minutes ago

Germany's BGR Assesses NextSource Materials' Molo Graphite Mine as Part of Federal Critical Minerals Study
Published on 05/14/2026 at 14:30, 44 minutes ago

Boron One Holdings Inc. Completes Its Jarandol Basin Exploration Program for 2026
Published on 05/14/2026 at 14:00, 1 hour 14 minutes ago

Adcore Reports First Quarter 2026 Results: Revenue Up 22% to CAD $8.5 Million, as APAC Grows 42% to CAD $5.5 Million

View all ACCESSWIRE

EQS Group

Published on 05/14/2026 at 14:55, 18 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 05/14/2026 at 14:54, 19 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 05/14/2026 at 14:53, 20 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 05/14/2026 at 14:53, 20 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 05/14/2026 at 14:52, 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

Les Echos

Published on 05/14/2026 at 09:03, 6 hours 10 minutes ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 21 hours 11 minutes ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 21 hours 14 minutes ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 18:00, 21 hours 14 minutes ago

DDV declaration au 30 avril 2026
Published on 05/13/2026 at 18:00, 21 hours 14 minutes ago

ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires

View all LES ECHOS COMFI WIRE